126 related articles for article (PubMed ID: 11483245)
1. Functional characterization of the human Huntington's disease gene promoter.
Holzmann C; Schmidt T; Thiel G; Epplen JT; Riess O
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):85-97. PubMed ID: 11483245
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of the rat huntingtin promoter.
Holzmann C; Mäueler W; Petersohn D; Schmidt T; Thiel G; Epplen JT; Riess O
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):227-34. PubMed ID: 9806905
[TBL] [Abstract][Full Text] [Related]
3. Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene.
Tanaka K; Shouguchi-Miyata J; Miyamoto N; Ikeda JE
J Biol Chem; 2004 Feb; 279(8):7275-86. PubMed ID: 14625278
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a minimal promoter element required for transcription of the mouse type II beta regulatory subunit (RII beta) of cAMP-dependent protein kinase.
Luo Z; Singh IS; Fujihira T; Erlichman J
J Biol Chem; 1992 Dec; 267(34):24738-47. PubMed ID: 1332964
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene.
Ng SW; Eder JP; Schnipper LE; Chan VT
J Biol Chem; 1995 Oct; 270(43):25850-8. PubMed ID: 7592770
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the Huntington's disease (HD) gene promoter.
Coles R; Caswell R; Rubinsztein DC
Hum Mol Genet; 1998 May; 7(5):791-800. PubMed ID: 9536082
[TBL] [Abstract][Full Text] [Related]
7. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene.
Zhu Q; Center MS
DNA Cell Biol; 1996 Feb; 15(2):105-11. PubMed ID: 8634138
[TBL] [Abstract][Full Text] [Related]
8. The human synapsin II gene promoter. Possible role for the transcription factor zif268/egr-1, polyoma enhancer activator 3, and AP2.
Petersohn D; Schoch S; Brinkmann DR; Thiel G
J Biol Chem; 1995 Oct; 270(41):24361-9. PubMed ID: 7592648
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio.
Karlovich CA; John RM; Ramirez L; Stainier DY; Myers RM
Gene; 1998 Sep; 217(1-2):117-25. PubMed ID: 9795179
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the neuronal L-type calcium channel alpha 1D subunit gene.
Kamp TJ; Mitas M; Fields KL; Asoh S; Chin H; Marban E; Nirenberg M
Cell Mol Neurobiol; 1995 Jun; 15(3):307-26. PubMed ID: 7553731
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells.
Matsuda K; Araki E; Yoshimura R; Tsuruzoe K; Furukawa N; Kaneko K; Motoshima H; Yoshizato K; Kishikawa H; Shichiri M
Diabetes; 1997 Mar; 46(3):354-62. PubMed ID: 9032089
[TBL] [Abstract][Full Text] [Related]
13. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the rat catechol-O-methyltransferase gene proximal promoter: identification of a nuclear protein-DNA interaction that contributes to the tissue-specific regulation.
Tenhunen J
DNA Cell Biol; 1996 Jun; 15(6):461-73. PubMed ID: 8672242
[TBL] [Abstract][Full Text] [Related]
15. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation.
Hayashi Y; Mori Y; Janssen OE; Sunthornthepvarakul T; Weiss RE; Takeda K; Weinberg M; Seo H; Bell GI; Refetoff S
Mol Endocrinol; 1993 Aug; 7(8):1049-60. PubMed ID: 8232304
[TBL] [Abstract][Full Text] [Related]
16. 12-O-tetradecanoyl-phorbol-13-acetate down-regulates the Huntingtin promoter at Sp1 sites.
Coles R; Birdsall M; Wyttenbach A; Rubinsztein DC
Neuroreport; 2000 Sep; 11(14):3157-61. PubMed ID: 11043541
[TBL] [Abstract][Full Text] [Related]
17. The expression of the human neuronal alpha3 Na+,K+-ATPase subunit gene is regulated by the activity of the Sp1 and NF-Y transcription factors.
Benfante R; Antonini RA; Vaccari M; Flora A; Chen F; Clementi F; Fornasari D
Biochem J; 2005 Feb; 386(Pt 1):63-72. PubMed ID: 15462673
[TBL] [Abstract][Full Text] [Related]
18. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
19. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Dunah AW; Jeong H; Griffin A; Kim YM; Standaert DG; Hersch SM; Mouradian MM; Young AB; Tanese N; Krainc D
Science; 2002 Jun; 296(5576):2238-43. PubMed ID: 11988536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
